Código QR (código de barras bidimensional)

Tumor size as a key determinant of treatment strategy and prognosis in stereotactic body radiotherapy for pulmonary metastases: a retrospective study

BACKGROUND: Stereotactic body radiotherapy (SBRT) is widely used for pulmonary metastases, but the optimal dose-fractionation strategy remains uncertain. Tumor size may critically influence both treatment selection and prognosis. MATERIALS AND METHODS: We retrospectively analyzed 173 metastatic lung...

Fuld beskrivelse

Na minha lista:
Principais autores: Kae Okuma, Tairo Kashihara, Koji Inaba, Kana Takahashi, Madoka Sakuramachi, Ayaka Nagao, Akane Yoshiba, Akikazu Kobori, Tongyu Gao, Shoki Nakamura, Hiroshi Igaki
Format: Artigo
Sprog:Inglês
Udgivet: Via Medica 2026-02-01
Serier:Reports of Practical Oncology and Radiotherapy
Fag:
stereotactic body radiotherapy (SBRT)
pulmonary metastases
tumor size
dose-fractionation
biological effective dose (BED)
local control
overall survival
Online adgang:https://journals.viamedica.pl/rpor/article/view/109095
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker